RxDoctor Payments Data

Thadeus Schulz, MD

Pathology · New York, NYNPI 1407983117

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 95th percentile of 448 pathology providers in New York.

See all pathology providers in New York

Medicare billing

Part B allowed, 2024
$455,473
Medicare patients
296
Services billed
3,900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$41,599
Abilify MaintenaAripiprazole15$39,813
JanuviaSitagliptin Phosphate31$33,089
JardianceEmpagliflozin13$19,706
LinzessLinaclotide15$12,211
FarxigaDapagliflozin Propanediol17$9,472
Memantine Hcl27$5,284
Cyclosporine14$3,481
Aripiprazole11$2,354
Albuterol Sulfate HfaAlbuterol Sulfate68$2,231
Amiodarone Hcl12$2,056
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$1,674
Gabapentin86$1,671
Nifedipine ErNifedipine32$1,007
Rosuvastatin Calcium30$875

Paid to pharmacies, not to this prescriber.

Other pathology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →